SCOTTO & ASSOCIES advises Pierre Bastid’s family office on flotation of Pharnext on Alternext Paris

Press release 30 Jun 2016

Firm Contact

Thomas Bourdeaut

+33 (0) 1 83 92 38 38

Press Contact

Anne Bassi

+ 33 (0) 1 40 46 07 27

Paris, 30 June 2016

Scotto & Associés advises Zaka, Pierre Bastid’s family office, on the flotation on Alternext Paris of Pharnext, a biopharmaceutical French company with an advanced range of drugs targeting neurodegenerative diseases.

Pharnext expects the flotation to generate between €36.4m and €48.2m. Subscriptions worth €9m have already been secured by Zaka, Truffle Capital and Ipsen Pharma as its historical shareholders.

The team at Scotto & Associés was Thomas Bourdeaut (partner) and François Bossé-Cohic.